Have Questions?

Global Headquarters

Tel: +44 (0)20 7377 0800
Fax: +44 (0)20 7349 5157

North America

Tel: 1-617-573-9450
Fax: 1-617-573-9542

Japan

Tel: +81 (0)80-1164-4754

Request a Demo

What our customers are saying

When I think of the future, I think of EvaluatePharma

Senior Director,
Global pharmaceutical company

EvaluatePharma Heading

EvaluatePharma Tools

NPV Analyzer

  • Interactive NPV discount cash flow model that helps you to value an asset
  • Unique, fully transparent models for global products
  • Complete flexibility to customize, save and download analyses
  • Edit key assumptions for any product NPV such as sales data, patent expiry, cost of capital and tax rate
  • Model impact of major events on product valuation: e.g., patent extensions, litigation and clinical trials
  • Analyze impact of product value on both share price and market capitalization

Calendar of Events

  • First fully comprehensive online calendar to track events impacting shareholder value
  • Key events are prioritized by commercial impact - the forecast effect of the event on the Company's stock price
  • Events are linked to comment and analysis from EP Vantage
  • Highlights potential event-based investment opportunities
  • Key events include:
    • US Product Approval (PDUFA)
    • US Product Approval (PDUFA) (sNDA/sBLA)
    • EU Product Approval
    • US FDA Advisory Committee
    • Phase III Trial Results
    • Phase II Trial Results
    • US Patent Date Uncertain
    • US Generic Launch

EP Vantage and Event Analyzer

  • Award-winning daily analysis of regulatory and patent decisions, marketing approvals, licensing deals and M&A
  • Timely financial analysis of pivotal events put into context with EvaluatePharma market data
  • Advanced intelligence on potential market catalysts weeks months ahead of other sources
  • Daily and Weekly Market Movers alerts offer the most comprehensive daily round up of share price movements plus the story behind the news
  • Unique access to interactive NPV Analyzer to quantify the impact on product & company valuation
  • EventAnalyzer delivers invaluable insights into the market events impacting global company share prices
  • View individual events by Company, Product, Therapy Area and Peer Group
  • Identify instantly which type of events and news are impacting company valuations
  • 100+ classifications: approvals, financial results, patent litigation, broker sentiment & competition

Peer Group Analyzer

  • Benchmark companies by country, region, sector, market cap, therapy area and more
  • Define your own peer groups and compare sales, forecasts, financial valuations, patents and licensing deals
  • Screen hundreds of companies for investment purposes or monitor the competitive environment

Merge Company & Company Rank

  • Evaluate potential combinations and gain insight into current merger activity
  • Create virtual companies incorporating all product, financial and company analysis
  • Assess new market share and ranking by various categories including total sales and forecast
  • Rankings based on market cap, market share, sales, pipeline products, therapeutic areas
  • Customize rankings on actual values, growth rates and more

NewsManager

  • Easy to search database of global industry press releases and EP Vantage articles
  • Search by pre-set categories or easily create your own highly specific searches
  • Customized daily news alerts to keep you ahead of the curve

Reporting and Exporting

  • Robust reporting tool drills down to level of detail you desire
  • Full flexibility to customize, edit and download any report into Excel or fully formatted PDF
  • Easy to save and share results so you can collaborate with colleagues

Archived Forecasts

  • Only available archive of consensus sales forecasts for the pharma and biotech market
  • Over 210,000 forecasts accessible starting January 2003
  • Details product progression or delay through R&D phases and the corresponding change in sales